Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 0920401 approvals

Amicogen, Inc.

Official website

KOSDAQ-listed industrial biotech producing cephalosporin precursor enzyme CX and antibody-purification Protein A resin.

As of 2026-10-10, Amicogen, Inc. has 1 Korean MFDS device approval, 27 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2000 and listed on KOSDAQ in 2013, Amicogen is an industrial biotech company specializing in specialty pharmaceutical enzymes and enzyme-based bio-materials. It develops and commercializes CX enzyme for manufacturing the cephalosporin precursor 7-ACA, SP enzymes for penicillin-class antibiotics, SC enzymes for cephalosporin-class antibiotics, Protein A resin for antibody purification, and culture media products, alongside healthcare materials (N-acetylglucosamine, D-chiro-inositol, pinitol, collagen peptide/tripeptide) and its K-NUTRA brand business. Since 2020, it has partnered with Lysando of Liechtenstein to commercialize an endolysin enzyme.

Products & technology

  • CX enzymeEnzyme for manufacturing 7-ACA, a cephalosporin antibiotic precursor
  • SP enzymesSynthetic enzymes for penicillin-class antibiotics including amoxicillin
  • SC enzymesSynthetic enzymes for cephalosporin-class antibiotics including cefotaxime
  • Protein A resinAffinity chromatography resin for antibody biopharmaceutical purification
  • Cell culture mediaCulture media for biopharmaceutical production
  • Healthcare materials (N-acetylglucosamine, D-chiro-inositol, pinitol, collagen peptide/tripeptide)Health functional ingredient materials
  • K-NUTRAConsumer brand business
  • Endolysin enzymeNext-generation antibiotic for treating superbugs

Regulatory approvals

data.go.kr

1 Korean MFDS device approvals · 2022

  • MFDSChemiluminescence assay(CLIA) analyzer2022-05-31
    Product approval · Class 1체외 수신 22-963 호

R&D and key agreements

Source: DART corporate disclosure

엔돌라이신 효소 · 슈퍼박테리아 감염 · 사업화 추진중 · Collaboration with Lysando (Liechtenstein) since 2020

Key disclosures

KRX KIND via OpenDART
Show 14 more events

Publications

PubMed · affiliation-matched
Show 17 more publications

Patents

KIPRIS · applicant-matched
Show 108 more patents

AI reads

MAA server logs · IP-verified
46
Times AI engines pulled Amicogen, Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

43
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

8
live 1
Last 7 days
36
live 3
Last 30 days
46
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot32
  • GoogleGoogleOther4
  • PerplexityPerplexityBot4
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Amicogen, Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Boditech Med Inc.1 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

PROTIA INC.1 shared

KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.

AHN-GOOK PHARMACEUTICAL Co., Ltd.1 shared

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

Precision Biosensor Inc.1 shared

KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.

PCL. Inc1 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

Sugentech, Inc.1 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

PeopleBio, Inc.1 shared

KOSDAQ-listed IVD company selling AlzOn and AlzOn+ blood-based oligomeric beta-amyloid tests for Alzheimer's risk assessment.

GC Medical Science Corporation1 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Micro Digital Co., Ltd.1 shared

KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.

DONG-A ST CO.,LTD1 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

SD BIOSENSOR INC.1 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

AHNLAB,INC.100

KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition